Back
AnaptysBio Vs. Fate Therapeutics Industry Stock Comparison
Buy
55
ANAB
AnaptysBio
Last Price:
25.07
Seasonality Move:
-7.52%
Sell
39
FATE
Fate Therapeutics
Last Price:
3.91
Seasonality Move:
9.33%
Buy
55
AnaptysBio (ANAB)
is a Buy
Is AnaptysBio a Buy, Sell or Hold?
- The current AnaptysBio [ANAB] share price is $25.07. The Score for ANAB is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ANAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics a Buy, Sell or Hold?
- The current Fate Therapeutics [FATE] share price is $3.90. The Score for FATE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- FATE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANAB Stock Price Chart
What is AnaptysBio's stock price today?
-
The AnaptysBio share price today is $25.07
The current trend is moderately bullish and ANAB is experiencing slight buying pressure.
FATE Stock Price Chart
What is Fate Therapeutics's stock price today?
-
The Fate Therapeutics share price today is $3.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing selling pressure, which indicates risk of future bearish movement.
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 55.84 | Buy |
| Chaikin Money Flow: | 41464 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.44 - 25.84) | Buy |
| Bollinger Bands (100): | (21.39 - 25.15) | Buy |
FATE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 34.28 | Sell |
| Chaikin Money Flow: | -1079883 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.81 - 4.85) | Sell |
| Bollinger Bands (100): | (4.25 - 7.09) | Sell |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.1 | Sell |
| 20-day SMA: | 23.74 | Buy |
| 50-day SMA: | 22.9 | Buy |
| 200-day SMA: | 20.56 | Buy |
| 8-day EMA: | 25.06 | Buy |
| 20-day EMA: | 24.23 | Buy |
| 50-day EMA: | 23.36 | Buy |
| 200-day EMA: | 21.8 | Buy |
FATE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.05 | Sell |
| 20-day SMA: | 4.1 | Sell |
| 50-day SMA: | 5.69 | Sell |
| 200-day SMA: | 4.05 | Sell |
| 8-day EMA: | 4.08 | Sell |
| 20-day EMA: | 4.35 | Sell |
| 50-day EMA: | 5.07 | Sell |
| 200-day EMA: | 5.53 | Sell |
AnaptysBio Earnings Growth & ANAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.07 per share, an increase this year of $0.20 per share, and an increase next year of $0.14 per share.
Fate Therapeutics Earnings Growth & FATE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.10 per share, and an increase next year of $0.09 per share.
AnaptysBio Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Fate Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||